Another study found that PTPN2 deficient T cells were more efficient in restraining AT3-OVA mammary carcinoma cells, but the PTPN2–/– OT-1 CD8 T cells expressed lower frequencies of PD-1+ or LAG-3+ cells (Wiede et al., 2020). The gene discussed is PTPN2; the disease is breast carcinoma.